⌘K

Home/Filings/4/0001171843-12-000015

4//SEC Filing

Capstone Therapeutics Corp. 4

Accession 0001171843-12-000015

$CAPSCIK 0000887151operating

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 3:27 PM ET

Size

8.2 KB

Accession

0001171843-12-000015

Insider Transaction Report

Form 4

Period: 2012-01-01

Capstone Therapeutics Corp.CAPS

HOLLIMAN JOHN M III

DirectorExecutive Chairman

Transactions

Award
Common Stock
2012-01-01+10,000→ 332,614 total
Award
Stock Option (Right to Buy)
2012-01-01+10,000→ 715,000 total
Exercise: $0.26From: 2012-01-01Exp: 2022-01-01→ Common Stock (10,000 underlying)

Holdings

Common Stock
(indirect: Valley Ventures III, LP)
1,568
Common Stock
(indirect: By Trust)
3,000

Footnotes (1)

[F1]Represents 10,000 shares of restricted stock issued pursuant to the Capstone Therapeutics Corp. 2005 Equity Incentive Plan, which are subject to a risk of forfeiture until vesting on 1-2-2013.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Capstone Therapeutics Corp.

CIK 0000887151

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887151

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 3:27 PM ET
Size: 8.2 KB

View on SEC.gov